Kathrin Möllenhoff

1. Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
   2025/03/27 by Verena Dzialas, Gérard N. Bischof, Kathrin Möllenhoff +2 · 1 citation
2. Simulation-Free Bayesian Power and Sample Size Calculations for Bayes Factors in Single-Arm Phase II Trials with Binary Endpoints
   2026/07/27 by Riko Kelter, Kathrin Möllenhoff
   Mathematics · #stat.ME #stat.AP